Literature DB >> 34410935

Authors' Reply.

An S De Vriese1,2.   

Abstract

Entities:  

Keywords:  cardiovascular disease; cardiovascular events; hemodialysis; randomized controlled trials; renal transplantation

Year:  2021        PMID： 34410935      PMCID： PMC8729833          DOI： 10.1681/ASN.2021060866

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  5 in total

1.  Utilization of direct-acting oral anticoagulation in solid organ transplant patients: A national survey of institutional practices.

Authors:  Alicia B Lichvar; Dana R Pierce; David Salerno; Patrick Klem; Georgina Waldman; Jeong M Park
Journal:  Clin Transplant       Date:  2020-04-06       Impact factor: 2.863

2.  Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Mark Crowther; John W Eikelboom; C Michael Gibson; John T Curnutte; John H Lawrence; Patrick Yue; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Andrew M Demchuk; Daniel J Pallin; Mauricio Concha; Shelly Goodman; Janet Leeds; Sonia Souza; Deborah M Siegal; Elena Zotova; Brandi Meeks; Sadia Ahmad; Juliet Nakamya; Truman J Milling
Journal:  N Engl J Med       Date:  2019-02-07       Impact factor: 91.245

3.  Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion.

Authors:  An S De Vriese; Gunnar Heine
Journal:  Nephrol Dial Transplant       Date:  2022-10-19       Impact factor: 7.186

4.  Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial.

Authors:  An S De Vriese; Rogier Caluwé; Hans Van Der Meersch; Koen De Boeck; Dirk De Bacquer
Journal:  J Am Soc Nephrol       Date:  2021-03-22       Impact factor: 14.978

5.  Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.

Authors:  Nina Haagenrud Schultz; Runar Lundblad; Pål Andre Holme
Journal:  J Med Case Rep       Date:  2018-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.